ATI CEO Sells Ahead of Earnings as Analysts Chase the Rally
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
ATI Inc. reports Q2 results on July 29 with the stock up 74% year-to-date — and its own CEO selling into the strength.
The most striking signal heading into Tuesday's print is the insider activity. CEO Kimberly Fields sold roughly $7.3 million in shares on July 7, executing multiple tranches at prices between $179 and $187. The stock has since rallied another 6% on the week to $197.80, meaning the sales look early in hindsight — but the sheer scale of the CEO offload, just three weeks before earnings, is a flag worth noting. Short interest, by contrast, tells a much quieter story. Bears hold just 2.9% of the free float, a level that has drifted up about 8% over the past month but remains too modest to suggest any real conviction on the short side. Borrow availability is essentially unlimited — shares available to lend run to more than 6,400% of current short interest — and cost to borrow is a negligible 0.37%. There is no squeeze pressure here, and shorts are not a meaningful force in either direction.
Options positioning has shifted modestly more cautious into the print. The put/call ratio has climbed to 0.66, above its 20-day average of 0.60 by roughly 1.2 standard deviations. That is not an extreme reading — the 52-week high is 1.97 — but the direction of travel is clear: put demand has been building steadily since mid-June, when the PCR sat near 0.30. Peers have moved broadly in the same direction this week. CRS gained 8.2%, WWD added 6.6%, and HWM rose 6.2%, suggesting ATI's weekly gain reflects sector tailwinds rather than a stock-specific re-rating.
The analyst debate centres on whether the aerospace and specialty energy momentum can offset persistent weakness elsewhere. Bulls point to the Specialty Energy segment's 9% year-on-year growth, mid-teens 2026 sales projections for that unit, and a 400 basis point margin improvement tied to commercial renegotiations. Recent analyst moves have been uniformly constructive: TD Cowen raised its target to $210 on July 13, Susquehanna lifted to $215 on July 9, and Keybanc moved to $211 at end of June — all maintaining positive ratings while stepping up targets by $25–30. The consensus mean target of $200 now sits fractionally below the current price of $197.80, which tells its own story: the Street has been chasing this rally, not leading it. Bears focus on declining sales in medical, electronics, and industrial end markets, a valuation multiple that trades several turns below peer CRS, and the risk that non-aerospace revenue remains too subdued to sustain the re-rating. The forward earnings momentum score ranks in the 80th percentile, providing fundamental cover for bulls, but the EV/EBIT factor scores in the bottom 13th percentile — a reminder that the stock is not cheap on any traditional measure.
The print is therefore less a test of whether ATI's aerospace franchise is healthy, and more a question of whether margin delivery and the trajectory of ex-A&D revenues can justify a stock that has outrun its own analyst targets.
Stocks in this article
See the live data behind this article on ORTEX.
Open ATI on ORTEX →How this article was generated
- Generated
- 26 Jul 2026, 04:03
- Data as of
- 26 Jul 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.